Results 241 to 250 of about 109,716 (338)

New data on limno-terrestrial rotifers of the world. [PDF]

open access: yesBiodivers Data J
Lukashanets D   +15 more
europepmc   +1 more source

Inflammatory niches as spatial drivers of disease mechanisms and targets for personalized treatment

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This study provides a comprehensive review of how spatial transcriptomics reveals disease‐specific inflammatory niches across multiple skin disorders, highlighting key immune–stromal, neuro–immune and metabolic interactions that were previously unappreciated in non‐spatial analyses. Abstract Disease states are increasingly recognized as being shaped by
Rundong Jiang   +3 more
wiley   +1 more source

Global consensus on the management of melanin hyperpigmentation disorders

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
A global Delphi consensus of 10 dermatology experts established evidence‐based recommendations for melanin hyperpigmentation disorders, providing unified classification, photoprotection guidance and treatment algorithms. This framework harmonizes terminology and supports individualized management across diverse skin types and health systems.
Thierry Passeron   +9 more
wiley   +1 more source

Is the Reindeer Lichen <i>Cladonia arbuscula</i> Really Producing Isousnic Acid? A Chemotaxonomy Query. [PDF]

open access: yesMolecules
Ísleifsdóttir D   +8 more
europepmc   +1 more source

Dermatology 2.0: Precision medicine for inflammatory skin diseases

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Digital immune mapping of transcriptomics profiles from inflammatory skin disease biopsies enables precise molecular diagnosis, quantification of immune modules and personalized therapy selection by matching dominant immune signatures to targeted treatments.
Jeremy Di Domizio   +4 more
wiley   +1 more source

Paired-omics-based exploration and characterization of biosynthetic diversity in lichenized fungi. [PDF]

open access: yesMicrob Genom
Singh G   +14 more
europepmc   +1 more source

Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In this interim analysis of the OLYMPIA long‐term extension trial, nemolizumab exhibited sustained efficacy and was well tolerated through 100 weeks, with most adverse events being mild/moderate. Patients showed clinically meaningful improvements in core signs and symptoms.
Franz J. Legat   +22 more
wiley   +1 more source

Home - About - Disclaimer - Privacy